Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T-cell responses at the host: tumour interface.

R A Robins

    Biochimica Et Biophysica Acta
    |December 17, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Tumor immunity involves intricate T-cell interactions and target cell modifications. Experimental models help identify key effector cells for tumor rejection, guiding future cancer immunotherapy strategies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Decreased interferon-β induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis.

    Acta neurologica Scandinavica·2016
    Same author

    Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.

    Acta physiologica (Oxford, England)·2015
    Same author

    T-cell subsets in tumour rejection responses.

    Immunology today·2014
    Same author

    Th17/Th1 phenotype in demyelinating disease.

    Cytokine·2010
    Same author

    Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis.

    Acta neurologica Scandinavica·2008
    Same author

    Kinetics of immune cell migration at the human ocular surface.

    The British journal of ophthalmology·2008
    Same journal

    Cumulative Contents.

    Biochimica et biophysica acta·2020
    Same journal

    Molecular Basis of Disease Cumulative Contents.

    Biochimica et biophysica acta·2020
    Same journal

    General Subjects Cumulative Contents.

    Biochimica et biophysica acta·2020
    Same journal

    Erratum to 'on the role of exchangeable hydrogen bonds for the kinetics of P680<sup>+·</sup> Q<sub>A</sub> <sup>-·</sup> formation and P680<sup>+·</sup> Pheo<sup>-·</sup> recombination in photosystem II' [Biochim. Biophys. Acta 1276 (1996) 35-44].

    Biochimica et biophysica acta·2019
    Same journal

    Oligomeric state of the light-harvesting complexes B800-850 and B875 from purple bacterium Rubrivivax gelatinosus in detergent solution.

    Biochimica et biophysica acta·2019
    Same journal

    Regulation of pigment content and enzyme activity in the cyanobacterium Nostoc sp. Mac grown in continuous light, a light-dark photoperiod, or darkness.

    Biochimica et biophysica acta·2019
    See all related articles

    Area of Science:

    • Immunology
    • Cancer Biology
    • T-cell immunology

    Background:

    • T-cell responses to tumors are complex, involving intricate cellular interactions.
    • Tumor cells exhibit surface variations and modifications due to the immune response.
    • Many cells infiltrating tumors may not actively participate in their destruction.

    Purpose of the Study:

    • To summarize complex cellular interactions in T-cell mediated anti-tumor responses.
    • To highlight the value of experimental tumor systems in understanding immune cell roles.
    • To explore the potential for predicting tumor immunogenicity and rejection based on biological features.

    Main Methods:

    • Review and synthesis of existing evidence on T-cell tumor interactions.
    • Analysis of cellular dynamics within experimental tumor systems.

    Related Experiment Videos

  • Comparative assessment of experimental models and human tumor responses.

    • Main Results:

    • T-cell effector cell populations and target tumor cell surfaces are highly complex and dynamic.
    • A significant proportion of tumor-infiltrating cells do not contribute to tumor destruction.
    • Heterogeneity exists in tumor rejection responses across different experimental systems.

    Conclusions:

    • Experimental tumor systems offer valuable insights into specific aspects of human anti-tumor immunity.
    • Defining the tumor immune response in the context of tumor biology could predict immunogenicity.
    • Further development in experimental models is crucial for advancing T-cell based cancer therapies.